E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/2/2013 in the Prospect News Convertibles Daily.

New Issue: Healthways prices upsized $125 million five-year convertibles to yield 1.5%, up 20%

By Rebecca Melvin

New York, July 2 - Healthways Inc. priced an upsized $125 million of five-year convertible senior notes at par to yield 1.5% with an initial conversion premium of 20% on Monday, according to a syndicate source.

There is an over-allotment option for $25 million.

Initially the Rule 144A offering was talked at $100 million in size with a $15 million over-allotment option.

Pricing came at the midpoint of talk, which was for a 1.25% to 1.75% coupon and 17.5% to 22.5% premium.

The deal was brought by joint active bookrunner J.P. Morgan Securities LLC and passive bookrunners SunTrust Robinson Humphrey Inc. and Morgan Stanley & Co. LLC.

The company entered into convertible note hedge and warrant transactions with one or more initial purchasers of the bonds.

The bonds are non-callable and have contingent conversion if shares rise to 130% of the conversion price. They have dividend protection via a make-whole table, and they have takeover protection.

Proceeds will be used to reduce the company's credit agreement debt and for general corporate purposes, including acquisitions, strategic partnerships and expansion strategies, as well as to pay the cost of the hedge transactions.

Healthways is a Nashville-based provider of well-being improvement solutions.

Issuer:Healthways Inc.
Issue:Convertible senior notes
Amount:$125 million, upsized from $100 million
Greenshoe:$25 million, upsized from $15 million
Maturity:July 1, 2018
Bookrunners:J.P. Morgan Securities LLC (active), SunTrust Robinson Humphrey Inc. and Morgan Stanley & Co. LLC (passive)
Coupon:1.5%
Price:Par, $1,000
Yield:1.5%
Conversion premium:20%
Conversion price:$19.46
Conversion ratio:51.3769
Call:Non-callable
Put:No
Contingent conversion:Yes, at 130%
Dividend protection:Yes, via make-whole table
Takeover protection:Yes
Call spread:Yes
Price talk:1.25%-1.75%, up 17.5%-22.5%
Pricing date:July 1
Settlement date:July 8
Stock symbol:Nasdaq: HWAY
Stock reference price:$16.22
Distribution:Rule 144A
Market capitalization:$543.8 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.